4.7 Article

TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD

Journal

NATURE NEUROSCIENCE
Volume 21, Issue 2, Pages 228-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41593-017-0047-3

Keywords

-

Categories

Funding

  1. ALS Association [17-IIP-353, 16-IIP-278]
  2. Emory Medicine Catalyst Funding Program
  3. Muscular Dystrophy Association [MDA348086]
  4. NIH [K08-NS087121, P30-NS055077, AG025688, R01-NS091299, R35-NS097261, R01-NS085207, R01NS091749, R01-NS093362, R01-AG053960]
  5. The Bluefield Project to Cure FTD
  6. Alzheimers Drug Discovery Foundation
  7. Alzheimers Association (ALZ)
  8. Alzheimers Research UK (ARUK)
  9. The Michael J. Fox Foundation for Parkinsons Research (MJFF)
  10. Weston Brain Institute Biomarkers Across Neurodegenerative Diseases Grant [11060]
  11. UBRP
  12. UA Provosts Office
  13. ARCS Fellowship Roche Foundation Award

Ask authors/readers for more resources

The cytoplasmic mislocalization and aggregation of TAR DNA-binding protein-43 (TDP-43) is a common histopathological hallmark of the amyotrophic lateral sclerosis and frontotemporal dementia disease spectrum (ALS/FTD). However, the composition of aggregates and their contribution to the disease process remain unknown. Here we used proximity-dependent biotin identification (BioID) to interrogate the interactome of detergent-insoluble TDP-43 aggregates and found them enriched for components of the nuclear pore complex and nucleocytoplasmic transport machinery. Aggregated and disease-linked mutant TDP-43 triggered the sequestration and/or mislocalization of nucleoporins and transport factors, and interfered with nuclear protein import and RNA export in mouse primary cortical neurons, human fibroblasts and induced pluripotent stem cell-derived neurons. Nuclear pore pathology is present in brain tissue in cases of sporadic ALS and those involving genetic mutations in TARDBP and C9orf72. Our data strongly implicate TDP-43-mediated nucleocytoplasmic transport defects as a common disease mechanism in ALS/FTD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available